is everyone on glp 1 GLP-1 drugs, even when they fail, are giving researchers new insight about obesity : NPR GLP-1 Medications: For Everyone? Experts

EVK, H., et al., Exposure to continuous darkness ameliorates gastric and colonic inflammation in the rat: Both receptor and non-receptor-mediated processes

10.3389/fonc.2025.1471110 4 AkanchiseT.AngelovaA

An alternate version called Rybelsus was approved in September 2019, also as a Type 2 diabetes treatment, and semaglutide received approval for weight loss in June 2021 under the brand name Wegovy

Este estudio demostr que tirzepatida en dosis de 5, 10 y 15mg logr una resolucin de la esteatohepatitis (sin empeoramiento de la fibrosis) en un 44%, 56% y 62% de los casos, respectivamente, en comparacin con un 10% en el grupo placebo